170 related articles for article (PubMed ID: 35143585)
21. Heterogeneity in risk factors for ductal and lobular breast carcinomas: A case-control study.
Dianatinasab M; Fararouei M; Daneshi N; Rezaian S; Mohammadianpanah M; Chaman R; Ghiasvand R
Int J Cancer; 2019 Dec; 145(11):2917-2925. PubMed ID: 30719718
[TBL] [Abstract][Full Text] [Related]
22. Associations between dietary patterns and the risk of breast cancer: a systematic review and meta-analysis of observational studies.
Xiao Y; Xia J; Li L; Ke Y; Cheng J; Xie Y; Chu W; Cheung P; Kim JH; Colditz GA; Tamimi RM; Su X
Breast Cancer Res; 2019 Jan; 21(1):16. PubMed ID: 30696460
[TBL] [Abstract][Full Text] [Related]
23. Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer.
Petrelli F; Barni S
Breast Cancer Res Treat; 2013 Nov; 142(2):227-35. PubMed ID: 24177758
[TBL] [Abstract][Full Text] [Related]
24. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
Di Meglio A; Freedman RA; Lin NU; Barry WT; Metzger-Filho O; Keating NL; King TA; Sertoli MR; Boccardo F; Winer EP; Vaz-Luis I
Breast Cancer Res Treat; 2016 Jun; 157(3):587-96. PubMed ID: 27271765
[TBL] [Abstract][Full Text] [Related]
25. Migraine and subsequent risk of breast cancer: a prospective cohort study.
Winter AC; Rexrode KM; Lee IM; Buring JE; Tamimi RM; Kurth T
Cancer Causes Control; 2013 Jan; 24(1):81-9. PubMed ID: 23143336
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
Phipps AI; Li CI; Kerlikowske K; Barlow WE; Buist DS
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1643-54. PubMed ID: 20501751
[TBL] [Abstract][Full Text] [Related]
27. Migraine as a risk factor for primary open angle glaucoma: A systematic review and meta-analysis.
Xu C; Li J; Li Z; Mao X
Medicine (Baltimore); 2018 Jul; 97(28):e11377. PubMed ID: 29995778
[TBL] [Abstract][Full Text] [Related]
28. Hypertension and breast cancer risk: a systematic review and meta-analysis.
Han H; Guo W; Shi W; Yu Y; Zhang Y; Ye X; He J
Sci Rep; 2017 Mar; 7():44877. PubMed ID: 28317900
[TBL] [Abstract][Full Text] [Related]
29. Relationship between menopausal symptoms and risk of postmenopausal breast cancer.
Huang Y; Malone KE; Cushing-Haugen KL; Daling JR; Li CI
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):379-88. PubMed ID: 21212063
[TBL] [Abstract][Full Text] [Related]
30. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age.
McDougall JA; Malone KE; Daling JR; Cushing-Haugen KL; Porter PL; Li CI
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1529-37. PubMed ID: 23833125
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
32. Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast.
Chikman B; Lavy R; Davidson T; Wassermann I; Sandbank J; Siegelmann-Danieli N; Halevy A
Isr Med Assoc J; 2010 Nov; 12(11):697-700. PubMed ID: 21243872
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensives and breast cancer risk.
Pines A
Climacteric; 2013 Dec; 16(6):728. PubMed ID: 24383097
[No Abstract] [Full Text] [Related]
34. Antihypertensive medications and breast cancer risk.
Hugon-Rodin J; Gompel A; Plu-Bureau G
JAMA Intern Med; 2014 Apr; 174(4):640-1. PubMed ID: 24711187
[No Abstract] [Full Text] [Related]
35. Antihypertensive medications and breast cancer risk.
Ji Y; Chen S
JAMA Intern Med; 2014 Apr; 174(4):640. PubMed ID: 24711186
[No Abstract] [Full Text] [Related]
36. Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study.
Nyante SJ; Dallal CM; Gierach GL; Park Y; Hollenbeck AR; Brinton LA
Am J Epidemiol; 2013 Aug; 178(3):359-71. PubMed ID: 23899816
[TBL] [Abstract][Full Text] [Related]
37. Antihypertensive medications and breast cancer risk-reply.
Li CI; Tang MT; Malone KE
JAMA Intern Med; 2014 Apr; 174(4):641. PubMed ID: 24711189
[No Abstract] [Full Text] [Related]
38. Regional variations in breast cancer incidence among California women, 1988-1997.
Reynolds P; Hurley SE; Quach AT; Rosen H; Von Behren J; Hertz A; Smith D
Cancer Causes Control; 2005 Mar; 16(2):139-50. PubMed ID: 15868455
[TBL] [Abstract][Full Text] [Related]
39. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies.
Lahart IM; Metsios GS; Nevill AM; Carmichael AR
Acta Oncol; 2015 May; 54(5):635-54. PubMed ID: 25752971
[TBL] [Abstract][Full Text] [Related]
40. Association between common risk factors and molecular subtypes in breast cancer patients.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
